Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 20, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 20, Issue 10 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 20, Issue 10 (2011)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Volume 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors

Ahmed I El-Sakka

Pages: 1305-1309

Published online: 16 Aug 2011

AbstractforAlleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors | Full Text | References | PDF (172.4 KB)

163 Views
11 CrossRef citations
0Altmetric

Discontinued Drug Perspective

Article

Discontinued drugs in 2010: cardiovascular drugs

Hong-ping Zhao, Xu-song Zhang & Bing-ren Xiang

Pages: 1311-1325

Published online: 26 Aug 2011

AbstractforDiscontinued drugs in 2010: cardiovascular drugs | Full Text | References | PDF (725.3 KB)

417 Views
6 CrossRef citations
0Altmetric

Original Research

Article

The safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs

Brigitte M Richard PhD, Laura R Ott, Dean Haan, Abram N Brubaker, Phaedra I Cole, Keith G Nelson, Paul E Ross, Marlon C Rebelatto & Paul E Newton

Pages: 1327-1341

Published online: 26 Aug 2011

AbstractforThe safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs | Full Text | References | PDF (859.7 KB)

627 Views
40 CrossRef citations
0Altmetric

Reviews

Article

Thymidylate synthase inhibitors for non-small cell lung cancer

Elena Galvani, Godefridus J Peters & Elisa Giovannetti MD PhD

Pages: 1343-1356

Published online: 09 Sep 2011

AbstractforThymidylate synthase inhibitors for non-small cell lung cancer | Full Text | References | PDF (515 KB)

517 Views
25 CrossRef citations
0Altmetric

Article

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches

Pamela Jo Harris MD & Keith C Bible

Pages: 1357-1375

Published online: 13 Sep 2011

AbstractforEmerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches | Full Text | References | PDF (374.1 KB)

387 Views
29 CrossRef citations
0Altmetric

Article

The clinical development of FLT3 inhibitors in acute myeloid leukemia

Steven Knapper DM BMBCh FRCPath MRCP

Pages: 1377-1395

Published online: 06 Sep 2011

AbstractforThe clinical development of FLT3 inhibitors in acute myeloid leukemia | Full Text | References | PDF (433.7 KB)

808 Views
48 CrossRef citations
0Altmetric

Article

Targeting Mcl-1 for the therapy of cancer

Bridget A Quinn, Rupesh Dash, Belal Azab, Siddik Sarkar, Swadesh K Das, Sachin Kumar, Regina A Oyesanya, Santanu Dasgupta, Paul Dent, Steven Grant, Mohamed Rahmani, David T Curiel, Igor Dmitriev, Michael Hedvat, Jun Wei, Bainan Wu, John L Stebbins, John C Reed, Maurizio Pellecchia, Devanand Sarkar & Paul B Fisher

Pages: 1397-1411

Published online: 19 Aug 2011

AbstractforTargeting Mcl-1 for the therapy of cancer | Full Text | References | PDF (535.7 KB)

1302 Views
155 CrossRef citations
0Altmetric

Article

Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?

David Bruce & Peng H Tan

Pages: 1413-1434

Published online: 25 Aug 2011

AbstractforBlocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look? | Full Text | References | PDF (419.8 KB) | Supplemental

260 Views
10 CrossRef citations
0Altmetric

Drug Evaluations

Article

Taribavirin in the treatment of hepatitis C

Paulina Deming & Sanjeev Arora

Pages: 1435-1443

Published online: 20 Aug 2011

AbstractforTaribavirin in the treatment of hepatitis C | Full Text | References | PDF (321.5 KB)

169 Views
5 CrossRef citations
0Altmetric

Article

Vorapaxar: a novel protease-activated receptor-1 inhibitor

Paul A Gurbel MD, Young-Hoon Jeong MD PhD & Udaya S Tantry PhD

Pages: 1445-1453

Published online: 06 Aug 2011

AbstractforVorapaxar: a novel protease-activated receptor-1 inhibitor | Full Text | References | PDF (252.8 KB)

677 Views
16 CrossRef citations
0Altmetric

Article

Entinostat for treatment of solid tumors and hematologic malignancies

Jeffrey Knipstein MD & Lia Gore MD

Pages: 1455-1467

Published online: 02 Sep 2011

AbstractforEntinostat for treatment of solid tumors and hematologic malignancies | Full Text | References | PDF (313.6 KB)

864 Views
87 CrossRef citations
0Altmetric

Appendix

Correction

Erratum

Page: 1469

Published online: 29 Aug 2011

CitationforErratum | Full Text | PDF (25.8 KB)

39 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.20, Iss.10, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?